Hyam Levitsky's Net Worth

$1.23 Million

Estimate Recalculated Jul 15, 2024 09:56AM EST

Who is Hyam Levitsky?

Hyam Levitsky has an estimated net worth of $1.23 Million. This is based on reported shares across multiple companies, which include Century Therapeutics, Inc., AGENUS INC, Replimune Group, Inc., and Juno Therapeutics, Inc..

SEC CIK

Hyam Levitsky's CIK is 0001375792

Past Insider Trading and Trends

2008 was Hyam Levitsky's most active year for acquiring shares with 4 total transactions. Hyam Levitsky's most active month to acquire stocks was the month of March. 2016 was Hyam Levitsky's most active year for disposing of shares, totalling 3 transactions. Hyam Levitsky's most active month to dispose stocks was the month of May. 2007 saw Hyam Levitsky paying a total of $45,300.00 for 15,000 shares, this is the most they've acquired in one year. In 2016 Hyam Levitsky cashed out on 28,872 shares for a total of $1,222,807.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Century Therapeutics, Inc. (IPSC) Snapshot price: $4.57

President R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
24K
—
—
24K
Mar 7
Form 4
—
0
—
—
0
Apr 12
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jan 25
Form 3
—
0
—
—
0
No matching records found

AGENUS INC (AGEN) Snapshot price: $0.6849

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Jun 11
Form 4
∞
15.38K
—
—
15.38K
Feb 27
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jun 7
Form 3
—
0
—
—
0
No matching records found

Replimune Group, Inc. (REPL) Snapshot price: $7.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jul 24
Form 3
—
0
—
—
0
No matching records found

Juno Therapeutics, Inc. No price found

EVP, Research & CSO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.54%
14.63K
—
—
131.33K
Feb 7
Form 4
-9.62%
-12.42K
$42.77
-$531,080.84
116.7K
Scheduled
Jun 17
Form 4
-11.30%
-16.45K
$42.04
-$691,726.16
129.12K
May 27
Form 4
—
0
—
—
0
Feb 2
Form 4
∞
145K
—
—
145K
May 28
Form 3
—
0
—
—
0
No matching records found